AIM STEP 10
Student Memory Support
Topic 23 — Breast Lump and Breast Cancer: Benign Disease, Investigation, Management and Prevention
4th Year MBBS • ENDOCRINE + REPRODUCTION
High-yield memory reinforcement for pathology, investigation, treatment, pharmacology, screening, prevention and professional communication.
Step structure follows the supplied Student Memory Support requirements. :contentReference[oaicite:0]{index=0}
1. High-Yield Flashcards
Tap each question to reveal the answer.
What four major components make up fibrocystic change?
Cysts, fibrosis, epithelial hyperplasia and adenosis.
Why can fibrocystic change produce a firm breast?
Cyst rupture can trigger inflammation followed by stromal fibrosis.
What is the basic microscopic change in sclerosing adenosis?
Increased acini within a lobule compressed and distorted by fibrosis.
What two tissue components make fibroadenoma a biphasic tumor?
Benign glandular epithelium and proliferating fibrous stroma.
Which histological structure characterizes intraductal papilloma?
Fibrovascular cores lined by epithelial and myoepithelial cells.
What hormonal imbalance causes gynecomastia?
Increased estrogenic influence relative to androgenic action.
What pathological event converts carcinoma in situ into invasive breast carcinoma?
Breach of the basement membrane with invasion into surrounding stroma.
Why does peau d’orange develop in breast carcinoma?
Dermal lymphatic obstruction causes edema while skin appendages remain tethered.
What are the three components of triple assessment of a breast lesion?
Clinical assessment, appropriate breast imaging and pathological tissue assessment.
Which imaging modality is particularly useful for distinguishing a cystic from a solid breast lesion?
Breast ultrasound.
Which mammographic findings raise suspicion of malignancy?
Spiculation, architectural distortion and suspicious clustered microcalcifications.
Which tumor markers guide major systemic treatment decisions in breast cancer?
Estrogen receptor, progesterone receptor and HER2 status.
How does tamoxifen benefit ER-positive breast cancer?
It binds estrogen receptors and reduces estrogen-driven tumor-cell proliferation in breast tissue.
What two important adverse effects should be remembered with tamoxifen?
Venous thromboembolism and endometrial hyperplasia/carcinoma.
Which level of prevention does mammographic screening represent?
Secondary prevention.
What postoperative mechanism causes arm lymphedema after axillary treatment?
Disruption of regional lymphatic drainage from the upper limb.
2. Mnemonics
Mnemonic Title
Fibrocystic Change Components
Mnemonic Word
C-FHA
Meaning
C = Cysts • F = Fibrosis • H = Hyperplasia • A = Adenosis
Mnemonic Title
Triple Assessment
Mnemonic Word
CIP
Meaning
C = Clinical assessment • I = Imaging • P = Pathology
Mnemonic Title
Breast-Cancer Prevention Levels
Mnemonic Word
PPST
Meaning
Primordial → Primary → Secondary → Tertiary
3. Memory Tables
Benign versus Suspicious Breast Lump
| Feature | Benign Pattern | Suspicious Pattern |
|---|---|---|
| Margin | Smooth, circumscribed | Irregular, poorly defined |
| Mobility | Freely mobile | Fixed or tethered |
| Consistency | Soft, cystic or rubbery | Hard |
| Skin / nipple | Usually unchanged | Tethering, retraction, peau d’orange |
Ultrasound versus Mammography
| Point | Ultrasound | Mammography |
|---|---|---|
| Best memory use | Cystic versus solid | Calcification and distortion |
| Useful setting | Young or dense breast | Screening and diagnostic imaging |
| Suspicious clue | Irregular, non-parallel, shadowing | Spiculation, distortion, microcalcification |
4. Rapid Revision Points — Last-Minute Revision
Must Remember:
- Fibroadenoma is a benign biphasic tumor composed of stromal and epithelial elements.
- Papilloma contains fibrovascular cores and can produce serous or bloody nipple discharge.
- Breast carcinoma becomes invasive after malignant cells breach the basement membrane.
- Nipple retraction results from fibrosis and traction on involved ducts.
- TNM stage increases with greater primary tumor extent, regional nodal disease and distant metastasis.
- Core biopsy provides tissue architecture and permits important biomarker assessment.
- ER/PR positivity identifies tumors likely to benefit from endocrine therapy.
- HER2-positive disease provides a target for HER2-directed treatment.
- Tamoxifen acts as an estrogen antagonist in breast tissue but has tissue-selective agonist effects elsewhere.
- Breast-cancer surgery may be complicated by seroma, shoulder stiffness and arm lymphedema.
KMU Trap: Screening detects existing disease early and therefore represents secondary prevention, while risk-reducing medication or surgery before cancer develops represents primary prevention.
5. Clinical Memory Hooks
Young woman with a smooth mobile breast lump
→
Think fibroadenoma and its circumscribed biphasic morphology.
→
Think fibroadenoma and its circumscribed biphasic morphology.
Breast lump with peau d’orange
→
Dermal lymphatic obstruction by carcinoma causing localized skin edema.
→
Dermal lymphatic obstruction by carcinoma causing localized skin edema.
ER-positive breast carcinoma
→
Estrogen-dependent growth makes endocrine therapy biologically relevant.
→
Estrogen-dependent growth makes endocrine therapy biologically relevant.
Tamoxifen user with calf swelling or abnormal uterine bleeding
→
Recall thromboembolism and endometrial stimulation.
→
Recall thromboembolism and endometrial stimulation.
6. Starred High-Yield Exam Points
- ⭐ Triple assessment = clinical assessment + imaging + pathological diagnosis.
- ⭐ Peau d’orange = dermal lymphatic obstruction caused by invasive breast carcinoma.
- ⭐ ER/PR-positive tumor = potential benefit from endocrine therapy.
- ⭐ Tamoxifen = SERM that antagonizes estrogen action in breast tissue.
- ⭐ Major tamoxifen cautions = venous thromboembolism and endometrial hyperplasia/carcinoma.
- ⭐ Screening mammography = secondary prevention.
- ⭐ Arm swelling after axillary treatment = lymphedema due to impaired lymphatic drainage.